APA (7th ed.) Citation

L, Z., YM, C., C, C., EJ, G., OR, H., J, M., . . . A, S. (2025). Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors. Journal for immunotherapy of cancer, 13(10), . https://doi.org/10.1136/jitc-2025-011865

Chicago Style (17th ed.) Citation

L, Zhu, et al. "Consensus-based Disease Definitions for Endocrine Immune-related Adverse Events of Immune Checkpoint Inhibitors." Journal for Immunotherapy of Cancer 13, no. 10 (2025). https://doi.org/10.1136/jitc-2025-011865.

MLA (9th ed.) Citation

L, Zhu, et al. "Consensus-based Disease Definitions for Endocrine Immune-related Adverse Events of Immune Checkpoint Inhibitors." Journal for Immunotherapy of Cancer, vol. 13, no. 10, 2025, https://doi.org/10.1136/jitc-2025-011865.